We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$354M
AUM Growth
+$43.2M
Cap. Flow
+$30.3M
Cap. Flow %
8.54%
Top 10 Hldgs %
31.72%
Holding
1,674
New
354
Increased
213
Reduced
237
Closed
746

Top Buys

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$23.5M
2
BMO icon
Bank of Montreal
BMO
+$13.2M
3
MPWR icon
Monolithic Power Systems
MPWR
+$10.1M
4
SILJ icon
Amplify Junior Silver Miners ETF
SILJ
+$9.5M
5
COPX icon
Global X Copper Miners ETF NEW
COPX
+$8.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.8M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$4.39M
3
MSFT icon
Microsoft
MSFT
+$3.76M
4
SGML icon
Sigma Lithium
SGML
+$3.53M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Financials 17.75%
3 Technology 15.74%
4 Industrials 7.52%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSHD icon
351
Goosehead Insurance
GSHD
$2.39B
$88K 0.02%
+1,200
New +$85.5K
TRP icon
352
TC Energy
TRP
$65.8B
$88K 0.02%
+1,600
New +$85.4K
UIS icon
353
Unisys
UIS
$210M
$88K 0.02%
+32,000
New +$99.9K
PPL
354
PPL Corp
PPL
$26.8B
$87K 0.02%
2,500
– –
LHAI
355
Linkhome Holdings
LHAI
$13.2M
$87K 0.02%
+11,500
New +$123K
AR icon
356
Antero Resources
AR
$11.3B
$86K 0.02%
2,500
-500
-17% -$16.9K
UNIT
357
Uniti Group
UNIT
$2.38B
$86K 0.02%
12,294
-100
-0.8% -$634
DNA icon
358
Ginkgo Bioworks
DNA
$488M
$85K 0.02%
10,300
-3,265
-24% -$35.2K
WMB icon
359
Williams Companies
WMB
$89.3B
$84K 0.02%
+1,400
New +$84.6K
FOX icon
360
Fox Class B
FOX
$24.4B
$83K 0.02%
+1,290
New +$75.3K
WEN icon
361
Wendy's
WEN
$1.65B
$83K 0.02%
+10,000
New +$86.3K
AYTU icon
362
AYTU BioPharma
AYTU
$24.7M
$82K 0.02%
31,600
+31,470
+24,208% +$70.6K
ECOR icon
363
electroCore
ECOR
$89.6M
$82K 0.02%
+18,435
New +$92.4K
NCNO icon
364
nCino
NCNO
$2.26B
$82K 0.02%
3,228
+498
+18% +$12.6K
BFLY icon
365
Butterfly Network
BFLY
$2.36B
$81K 0.02%
+21,500
New +$58.5K
CAVA icon
366
CAVA Group
CAVA
$8.43B
$80K 0.02%
1,376
-7,905
-85% -$441K
RR icon
367
Richtech Robotics
RR
$385M
$80K 0.02%
+24,802
New +$110K
TERN
368
DELISTED
Terns Pharmaceuticals
TERN
$80K 0.02%
+2,000
New +$46.2K
PTON icon
369
Peloton Interactive
PTON
$2.44B
$79K 0.02%
12,890
-6,613
-34% -$46.5K
TER icon
370
Teradyne
TER
$64.2B
$79K 0.02%
412
-11,090
-96% -$1.9M
BRSL
371
Brightstar Lottery PLC
BRSL
$2.15B
$77K 0.02%
5,000
– –
MGNI icon
372
Magnite
MGNI
$3.53B
$77K 0.02%
4,775
+4,761
+34,007% +$79K
LUNG icon
373
Pulmonx
LUNG
$92.8M
$76K 0.02%
34,500
+16,134
+88% +$30.3K
SLB icon
374
SLB Ltd
SLB
$77.3B
$76K 0.02%
2,000
-1,048
-34% -$38K
VNO icon
375
Vornado Realty Trust
VNO
$7.41B
$76K 0.02%
+2,300
New +$84K
13 14
15
16 17

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

FNY Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, FNY Investment Advisers held 1,674 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FNY Investment Advisers deployed $30.3M of net new capital in Q4 2025, opening 354 new positions and adding to 213 existing holdings. Its largest new stake was Cidara Therapeutics: 145,533 shares worth $32.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sibanye-Stillwater, an estimated $4.39M trimmed.

  • FNY Investment Advisers's largest Q4 2025 buy was Cidara Therapeutics: 145,533 shares worth $32.1M.
  • FNY Investment Advisers added most to Morgan Stanley in Q4 2025, an estimated $6.17M increase.
  • FNY Investment Advisers's biggest Q4 2025 reduction was Sibanye-Stillwater, cutting an estimated $4.39M.
  • FNY Investment Advisers fully exited Verona Pharma in Q4 2025, selling an estimated $15.8M.
  • FNY Investment Advisers's ten largest holdings make up 32% of its $354M portfolio in Q4 2025.
  • FNY Investment Advisers opened 354 new positions and closed 746 in Q4 2025.
  • FNY Investment Advisers's portfolio value rose 14% quarter-over-quarter to $354M.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.